S22L (p.Ser22Leu) variant of PSEN2 (Presenilin-2)

S22L (p.Ser22Leu) in PSEN2 (Presenilin-2) is a missense change. Clinical records from ClinVar and UniProt describe it as uncertain significance in the context of Alzheimer disease 4. The available variant effect predictions contribute to a CATVariant prioritization score of 0.50 / 1. The record also includes population frequency data and structural context.

S22L (p.Ser22Leu) variant details